BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

PLoS By Category | Recent PLoS Articles
Biochemistry - Hematology - Immunology - Molecular Biology

Strain-Dependent Differences in Bone Development, Myeloid Hyperplasia, Morbidity and Mortality in Ptpn2-Deficient Mice
Published: Tuesday, May 08, 2012
Author: Florian Wiede et al.

by Florian Wiede, Sock Hui Chew, Catherine van Vliet, Ingrid J. Poulton, Konstantinos Kyparissoudis, Tedjo Sasmono, Kim Loh, Michel L. Tremblay, Dale I. Godfrey, Natalie A. Sims, Tony Tiganis

Single nucleotide polymorphisms in the gene encoding the protein tyrosine phosphatase TCPTP (encoded by PTPN2) have been linked with the development of autoimmunity. Here we have used Cre/LoxP recombination to generate Ptpn2ex2-/ex2- mice with a global deficiency in TCPTP on a C57BL/6 background and compared the phenotype of these mice to Ptpn2-/- mice (BALB/c-129SJ) generated previously by homologous recombination and backcrossed onto the BALB/c background. Ptpn2ex2-/ex2- mice exhibited growth retardation and a median survival of 32 days, as compared to 21 days for Ptpn2-/- (BALB/c) mice, but the overt signs of morbidity (hunched posture, piloerection, decreased mobility and diarrhoea) evident in Ptpn2-/- (BALB/c) mice were not detected in Ptpn2ex2-/ex2- mice. At 14 days of age, bone development was delayed in Ptpn2-/- (BALB/c) mice. This was associated with increased trabecular bone mass and decreased bone remodeling, a phenotype that was not evident in Ptpn2ex2-/ex2- mice. Ptpn2ex2-/ex2- mice had defects in erythropoiesis and B cell development as evident in Ptpn2-/- (BALB/c) mice, but not splenomegaly and did not exhibit an accumulation of myeloid cells in the spleen as seen in Ptpn2-/- (BALB/c) mice. Moreover, thymic atrophy, another feature of Ptpn2-/- (BALB/c) mice, was delayed in Ptpn2ex2-/ex2- mice and preceded by an increase in thymocyte positive selection and a concomitant increase in lymph node T cells. Backcrossing Ptpn2-/- (BALB/c) mice onto the C57BL/6 background largely recapitulated the phenotype of Ptpn2ex2-/ex2- mice. Taken together these results reaffirm TCPTP's important role in lymphocyte development and indicate that the effects on morbidity, mortality, bone development and the myeloid compartment are strain-dependent.
  More...